Caption Management, LLC Cassava Sciences Inc Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $9,797 - $30,636	600 New	600 $25,000
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $1.45 Million - $4.04 Million	45,000 New	45,000 $3.85 Million
Q3 2020 Nov 16, 2020	SELL	$2.86 - $11.51 $94,957 - $382,155	-33,202 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $67,732 - $320,067	33,202 New	33,202 $103,000

195

13.7M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.